All Pharma News
Amgen Wins Ruling on Patents for Kyprolis Cancer Drug

Amgen Wins Ruling on Patents for Kyprolis Cancer Drug
Christopher Yasiejko BLOOMBERG
05 May 2020
Share Share
After exiting troubled Merrimack, former CEO becomes new chief at Yumanity

After exiting troubled Merrimack, former CEO becomes new chief at Yumanity
Ben Adams FIERCE BIOTECH
10 Jul 2019
Share Share
Natco, Onyx settle cancer drug patent litigation

Natco, Onyx settle cancer drug patent litigation
ECONOMIC TIMES
01 Jun 2019
Share Share
Natco settles patent dispute with Onyx for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx for blood cancer drug Carfilzomib
MONEYCONTROL
31 May 2019
Share Share
Natco, Onyx settle cancer drug patent litigation

Natco, Onyx settle cancer drug patent litigation
ECONOMIC TIMES
30 May 2019
Share Share
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.

Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
PATENT LITIGATION
24 Nov 2018
Share Share
Cerdelga (eliglustat): Genzyme vs. Dr. Reddy’s Labs

Cerdelga (eliglustat): Genzyme vs. Dr. Reddy’s Labs
PATENT LITIGATION
24 Nov 2018
Share Share
Nexavar (sorafenib tosylate) : Bayer HealthCare vs. Apotex Inc.

Nexavar (sorafenib tosylate) : Bayer HealthCare vs. Apotex Inc.
PATENT LITIGATION
19 Oct 2018
Share Share
Kyprolis® (Carfilzomib) : Onyx Therapeutics v. Cipla Limited

Kyprolis® (Carfilzomib) : Onyx Therapeutics v. Cipla Limited
PATENT LITIGATION
20 Apr 2018
Share Share
Peloton`s Appoints Helen S. Kim, M.B.A. & David Chang, M.D., Ph.D. to BOD

Peloton`s Appoints Helen S. Kim, M.B.A. & David Chang, M.D., Ph.D. to BOD
PRESS RELEASE
22 Mar 2018
Share Share